World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 30 April 2018
Main ID:  ISRCTN26732484
Date of registration: 01/06/2017
Prospective Registration: No
Primary sponsor: Maastricht Universitair Medisch Centrum
Public title: A comparison between cardiac output monitoring using (invasive) pulmonary artery catheter and (noninvasive) thoracic electrical bioimpedance
Scientific title: Accuracy, precision and trending ability of electrical cardiometry cardiac output versus pulmonary artery thermodilution method: a prospective study
Date of first enrolment: 18/02/2009
Target sample size: 50
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN26732484
Study type:  Observational
Study design:  Prospective observational study (Diagnostic)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name: Boris    Cox
Address:  Maastricht Universitair Medisch Centrum P. Debyelaan 25 PB 5800 6202 AZ Maastricht Netherlands
Telephone: +31 (0)43 38765606
Email: b.cox@mumc.nl
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Scheduled for cardiac surgery
2. No contra-indication for the use of the pulmonary artery thermodilution method
3. Aged 18 and older

Exclusion criteria: 1. Contra indication for the use of the pulmonary artery thermodilution method
2. Under the age of 18


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Measurement of cardiac output with different devices in patients scheduled for cardiac surgery.
Circulatory System
Measurement of cardiac output with different devices in patients scheduled for cardiac surgery.
Intervention(s)
After obtaining written informed consent of each patient, participants are randomly sampled from patients undergoing cardiac surgery. They receive the standard level of care during surgery. After induction of anesthesia, a pulmonary artery catheter (PAC) and the AesculonTM device are placed on the participant. The index test is a thoracic electrical bioimpedance cardiac output monitor (Aesculon, Osypka Medical, Berlin, Germany). The reference test was a pulmonary artery catheter (Edwards Life sciences Corporation, Irvine, CA, USA, Continuous Cardiac Output VIP catheter with SvO2, model 746F8).

The only difference to standard care was the placement of four additional electrocardiography electrodes. Two electrodes are placed in the neck and two are placed at the thoracic level. Only data from standard monitoring and bioimpedance were recorded. There were no benefits or risk for patients taking part in this observational study.

All measurements are performed at certain time points and there was no interference with standard care and monitoring. There was no need for follow up within this study group. Measurements are performed at six time points: after induction and prior to incision (T1), prior to cannulation of the aorta (T2), ten minutes after protamine administration (T3), 30 minutes after arrival in the ICU (T4), 1 hour after extubation (T5), and one day post-operatively at 08.00 AM (T6).
Primary Outcome(s)
1. Accuracy and precision are measured using Bland Altman analysis by comparing results from the clinical gold standard pulmonary artery catheter to the results from the new device, the bioimpedance cardiac output monitor at 6 time points, after induction and prior to incision, prior to cannulation of the aorta, ten minutes after protamine administration, 30 minutes after arrival in the ICU, one hour after extubation, and one day post-operatively.
2. Polar plot methodology was used to objectify trending ability of the new technique ( AesculonTM).
Secondary Outcome(s)
Our secondary aim was to assess whether the surgical incision, and therefore the interruption of the continuity of the skin of the thoracic cavity and opening of the cavity itself, could be an important factor in the reported discrepancy between the two instruments.
Secondary ID(s)
MEC 08-4-075
Source(s) of Monetary Support
Maastricht Universitair Medisch Centrum
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Institutional review board of the Maastricht University Medical Center, 15/12/2008, ref: MEC 08-4-075
Results
Results available: Yes
Date Posted:
Date Completed: 12/11/2010
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history